References
DeAngelis LM (1999) Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol 43:249–257
Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18:3144–3150
Omuro AM, Ben-Porat LS, Panageas KS, Kim AK et al (2005) Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol 62:1595–1600
Harder H, Holtel H, Bromberg JEC, Poortmans P (2004) Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 62:544–547
Fitzgerald PM, Jankovic J (1989) Lower body parkinsonism: evidence for vascular etiology. Mov Disord 4:249–260
Lai R, Abrey LE, Rosenblum MK, DeAngelis LM (2004) Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology 62:451–456
Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1:426–436
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Milia, A., Pilia, G., Mascia, M.G. et al. Treatment-induced leukoencephalopathy in primary CNS lymphoma presenting as lower body parkinsonism. J Neurooncol 100, 281–283 (2010). https://doi.org/10.1007/s11060-010-0160-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-010-0160-6